Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces.1 Over time, this can lead to serious damage to the heart, blood vessels, eyes, kidneys, and nerves.2 The continuum of care for diabetes requires an integrated multidiscplinary approach, and the coordination of medication management is a critical element to achieving favorable health outcomes
Diabetes
BD understands the challenges faced by pharmaceutical companies that serve people with diabetes
- Diabetes
- Addressing Your Needs
Diabetes
Addressing Your Needs
Proven solutions
-
Solutions including the BD Vystra™ Disposable Pen, BD Physioject™ Disposable Autoinjector and BD Hypak™ for Biotech Glass Prefillable Syringe are accompanied by comprehensive documentation packages including comparative human factors data* to help de-risk generic and biosimilar combination product development.
Designed with patients in mind
Customizable options
-
BD Medical – Pharmaceutical Systems can help you customize your pre-fillable syringe systems with a variety of options, including backstops, biotech plunger stoppers and plunger rods, based on your particular specifications. We also offer printing services to put gradients or other information directly on your syringe.
Supply Resiliency
Choose BD to bring your drug to market
Backed by more than 60 years of experience, BD prefillable syringes and
services support medication delivery to benefit you, patients and clinicians.
Explore our products
BD Hypak™ for Biotech Glass Prefillable Syringe
BD Neopak™ Glass Prefillable Syringe
BD SCF" PremiumCoat® Plunger Stopper
BD SCF™ FluroTec® 4023/50 Plunger Rod Stopper
BD Physioject™ Disposable Autoinjector 1 mL
BD Vystra™ Disposable Pen
PremiumCoat is a registered trademark of Aptar Pharma
FluroTec is a registered trademark of West Pharmaceutical Services, Inc.
* For selected configurations
- World Health Organization - Diabetes - April 2023 - https://www.who.int/news-room/fact-sheets/detail/diabetes
- World Health Organization - Diabetes - https://www.who.int/health-topics/diabetes#tab=tab_1
- BD Vystra Design Verification Executive Summary Report [Internal Report] 2021
- A simulated study of acceptance, preference and willingness to adopt of a new pen injector (BD Vystra™) [internal study], Pont-de-Claix, FR: Becton Dickinson and Company; 2014
- Physioject™ Design Input Specification [Internal report]. Pont-de-Claix, FR: Becton, Dickinson and Company, 2014
- Physioject™ external R&D document. Design Control Evidence of BD Physioject™ with Hypak for BTH 1mL Long Size [external report]. Pont-de-Claix, FR: Becton, Dickinson and Company, 2021
- Physioject™ Design Verification Report [Internal report]. Pont-de-Claix, FR: Becton, Dickinson and Company, 2014
- BDM-PS Financial file November 2023, “Actual FY23” Perimeter